Literature DB >> 35092401

Factors Influencing Demand for Medical Cannabis Use among Cancer Patients in the North of Thailand.

Alongkorn Sukrueangkul1, Nitchatorn Panomai2, Wongsa Laohasiriwong2, Chutikan Sakphisutthikul2, Surachai Phimha2.   

Abstract

OBJECTIVE: Cancer treatments often cause side effects. Cannabis is a plant that has been studied and used to treat and relieve side effects from modern medicine. Medical cannabis (MC) was legalized in Thailand in 2019 with limited research on demand for its use. Therefore, this study aimed to identify factors associated with demand for MC use among cancer patients in the North of Thailand.
METHODS: This analytical cross-sectional study administered a multistage random sampling to recruit 1,284 cancer patients in northern Thailand to response a self-administered structured questionnaire. Generalized Linear Mixed Model (GLMM) was used to identify the determinants of demand for MC use among the population, presented adjusted odds ratios (adj.OR), 95% confidence intervals (95% CI), and p-values. RESULT: Nearly half of the respondents reported demand to use MC (44.0%). The factors that were significantly associated with demand to use MC included had high levels of health literacy about MC (adj.OR = 5.70; 95% CI: 4.08 to 7.96), higher levels of social support (adj.OR =5.50; 95% CI: 3.60 to 8.39), positive attitudes toward MC use (adj.OR = 2.56; 95% CI: 1.83 to 3.56), aged less than 30 (adj.OR =1.89; 95% CI: 1.21 to 2.93), diagnosis with cancerfor more than 12 months ago (adj.OR =1.73; 95% CI: 1.19 to 2.52) when controlling effect of other covariates.
CONCLUSION: We found substantial demand for MC use among cancer patients. Health literacy,social support, attitudes about MC, age, and duration of having cancer were significantly associated with demand for MC use. Therefore, improving health literacy and social support, especially among older cancer patients, could help increasing demand for MC as a complementary medicine to treat cancers.

Entities:  

Keywords:  alternative medicine; contemporary medicine; ganja; marijuana

Mesh:

Substances:

Year:  2022        PMID: 35092401      PMCID: PMC9258673          DOI: 10.31557/APJCP.2022.23.1.319

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


Introduction

While significant advancements in cancer therapy have been achieved, cancerremains a major medical and public health problem (Markham et al., 2020). Malignancies ranked as the second leading cause of death worldwide in 2018, accounting for an estimatedof 9.6 million deaths (WHO, 2018).The burden of cancer in Thailand is similarly significant, with more than 170,000 cancer cases and 114,000 cancer deathsrecorded in 2018, comprising over36% of the prematuredeaths attributable to non-communicable disease (WHO, 2020).Cancers of the liver, lung, colon and rectum, breast, stomach, and gallbladder are the most common sites for malignancy in Thailand, each contributing from 1 to 5% of all total deaths.Incidence of cancer types differs among the country’s regionsdue to differences in cultural and lifestyle patterns (Virani et al., 2017). Liver and lung cancers, in particular,are expected to increase in the north and northeast of the country.The magnitude of the problem requires not only sufficient access to the curative sector but also the integration of public health into optimal efforts for cancer diagnosis and therapy. The main goal should be to prolong the patient’s life with the best possible quality of life (QOL) (“WHO | Cancer control. Knowledge into action,” n.d.). Cannabis is a plant that has been studied and used to relieve side effects from existing cancer treatments. The primary group of active chemicalsin cannabis is cannabinoids with several of these compounds used as medicinal substances.The two most commonly used compounds are delta-9 tetrahydrocannabinol (THC) and Cannabidiol (CBD),with both chemicals acting through the endocannabinoid system (Lal et al., 2021). These cannabinoids have been used as a pain reliever, antiemetic drug in chemotherapy treatment, appetite stimulant, stress reliever, and sleep aid (Abrams and Guzman, 2015). The use of cannabis in cancer patients, however, can cause side effects such as dry mouth, nausea, vomiting, confusion. Special attention is needed for older adults with cardiovascular disease in whom palpitations, tachycardia, high blood pressure can occur, as well as people with mental illness (Whiting et al.,2015; Sexton et al., 2016). In Thailand, medical cannabis (MC) remains a new concept with only limited research available. The Thai government authorized the use of cannabis for medical purposes in 2019. The rapid introduction of MC has led to misconceptions and controversies, such as 1) the belief that cannabis can cure all diseases, 2) the growth of illegal cannabis trading through online media, and 3) the pursuit of marijuana among ineligible patients (SuphanchaimatandPavasuthipaisit, 2018; SaengkhamandOngkasingh, 2020). MC use among cancer patients can be considered a form of complementary and alternative medicine (CAM). Demographics associated with use of CAM among cancer patients around the world have shown some notable trends. For example, young women with cancer in Italy were more like to use CAM therapies, including dietary supplements and herbs (Bonacchi et al.,2014). Similarly, in Ghana, being young, married, female, and having a high level of education were all factors that led to increased CAM use following cancer diagnosis (Yarneyet al.,2013). These trends mimic trends in the broader population. For example, in Norway, CAM usage was higher in younger, female, and educated individuals (Kristoffersen et al.,2021). Clinical characteristics are also important. Patients that have undergone treatment for a long duration of time or had less success in treatment were more like to have higher awareness about CAM, which can affect subsequent usage (Choi et al.,2021). An advanced stage of cancer has been shown to be strongly related to CAM use (Naja et al.,2015). Increased usage of CAM has been associated among rural elderly cancer and among those who have more than one comorbidity (Ayele et al., 2017). Besides demographics and clinical characteristics, social attitudes and previous experience can be an important factor in determining CAM usage. For example, social networks and encouragement from family can strongly influence choices to use CAM (Labidi et al.,2020). Expectations of CAM effectiveness or dissatisfaction with current treatment have also been shown to increase the use of CAM (Tangkiatkumjai et al.,2020; Bauml et al., 2015). However, health literacy regarding CAM is also important, with young men having lower levels of health literacy (Sharoni et al.,2019). Overall, while cultural and societal differences affect attitudes towards CAM among cancer patients, some similar trends are observed globally, including generally being associated with females, younger age, higher income, more advanced stages of cancer, and previous experience with or knowledge about CAM. Considering cannabis use in particular, MC may be slightly different. For example, MC has been shown to be more common among males compared to females (Haug et al.,2017). Furthermore, there may be higher levels of stigma associated with MC use (Leos-Toro et al., 2018). Therefore, given the importance of culture, demographics, and laws, as well as the relative novelty of MC in Thailand, there is a need to understand the role of these factors in affecting MC use among cancer patients in Thailand. Given the higher incidence of cancer in northern Thailand relative to the rest of the country, we were interested in studying demand of MC use among cancer patients in the region. This study aimed to identify factors associated with demand of MC use among cancer patients in northern Thailand.

Materials and Methods

Study design This cross-sectional study was conducted using an anonymous paper-based survey administered in out-patient cancer clinics located at six public hospitals within northern Thailand (within Ministry of Public Health Regions 1 to 3). The six hospitals were multistage randomly selected. ied Participants Any cancer patient with a cancer diagnosis, receiving treatment at one of the studied hospitals, aged 18 or older, and able to read and write in Thai were eligible for inclusion in the study. Recruitment took place between July 2020 and January 2021. Participants were recruited by register nurse. Participants who received end stage cancer diagnosis or whose severe symptoms prevented them from providing information were excluded. Instrument Data was collected using a self-administered questionnaire that include 6 items with structured question format about MC. Social support were assessed using social support questionnaire, which was coded into a score from 20 to 100. Attitudes were assessed using attitude about MC questionnaires, which was coded into a score from 15 to 45. Knowledge about MC were assessed using knowledge about MC questionnaires, which was coded into a score from 0 to 20, and health literacy about MC, were assessed using health literacy instruments, which was coded into a score from 47 to 188 and score from all questionnaires were converted to percentages. The survey was developed by the project team specifically for this research based on research questions and relevant literature. The questionnaire was test by five experts for validity. The questionnaire was trialed to test the reliability. The Cronbach’s Alpha was 0.88 for sociodemographic factors, 0.86 for social support, 0.81 for attitudes, 0.94 for health literacy, and 0.84 for demand of MC use among cancer patients. The Kuder - Richardson was 0.75 for knowledge about MC use questionnaires. Data Analysis Data was entered into a database using STATA software with 100% of data entry checked for accuracy. Simple logistic regression was used to identify association between each individual independent variable and demand of MC use. The independent factors that had p-value smaller than 0.25 (Bursac et al.,2008) were processed in the multivariable analysis using a generalized linear mixed model (GLMM) to identify factors associated with demand of MC use when controlling for the effect of other covariates. The magnitude of effectswere presented as adjusted odds ratio (adj.OR) and 95% confidence interval (CI), using a statistical significance levelα=0.05. Ethical considerations This research has been approved by the KhonKaen University Ethics Committee in Human Research base on the Declaration of Helsinki and the ICH Good Clinical Practice Guidelines. Record No. 4.3.01: 23/2020, Reference No. HE632157.

Results

Patient Characteristics In total, 1,284 cancer patients were included in the final analysis.Most of the participants were females (61.7%), with a mean age of 58.3 ± 13.0 years (Table 1). Most reported being currently married or in domestic partnership (74.3%), having completed only primary school (64.7%), and earning amonthly income less than or equal to 10,000 THB (around 312 USD). Among possible health coverage schemes, around three quarters (76.3%) were covered under the Universal Coverage Scheme, which provides public health insurance coverage to those ineligibles for social health insurance (Social Security Scheme) or government fringe benefits (Civil Servant Medical Benefit Scheme). Many participants (69.4%) hada comorbidity in addition to cancer. The most common cancer sites were breast (30.8%), followed by colorectal (20.9%), and lung (9.7%). Theaverage time from diagnosis of cancer was 10.23 months with a large amount of variability (±16.57 months).Most participants (69.4%) were categorized into a group with cancer stage of II, III, or IV. Treatment included chemotherapy (59.3%), radiation therapy (19.8%), and surgery (13.2%). Almost one-third of participants had a high level of social support. (Table 1).
Table 1

Socio-Demographic Factors among Cancer Patients in the Northern of Thailand. (n=1,284)

FactorsNumberPercentage
Gender
Female79261.7
Male49238.3
Age group (years)
< 30403.1
≥301,24496.9
Mean ± S.D. = 58.3 ± 13.0
Current relationship status
Married/domestic partnership95474.3
Divorced/separated/widowed22717.7
Single1038
Highest education level
Primary school83164.7
Junior high school and higher45335.3
Monthly income (THB)
<10,00086767.5
≥10,00041732.5
Mean ± S.D. = 11,425.25 ± 13,598.54
Scheme
Universal Coverage97976.3
Civil Servant Medical Benefit19515.2
Social Security1108.6
Health status
Comorbidity89169.4
No comorbidity39330.6
Primary cancer site
Breast39530.8
Colorectal26820.9
Lung1249.7
Lymphoma927.2
Cervical745.8
Other32725.4
Time from diagnosis with cancer (month)
< 121,07262.6
≥1221237.4
Mean ± S.D. = 10.27±16.57
Current treatment received
Chemotherapy76259.3
Radiation therapy25419.8
Surgery16813.2
Other1007.8
Stage of Cancer
Unknown17913.9
In situ917.1
Stage I20015.6
Stage II-IV81469.4
Received information about cannabis
Yes1,13388.2
No15111.8
FactorsNumberPercentage
Source of MC information
Family96575.2
Television67552.6
Social media47637.1
Doctor, pharmacist, and medical staff14211.1
Newspaper/ brochures13210.3
Radio896.9
Academic article836.5
Thai traditional medicine755.8
Other272.1
Social support
Low (less than 60 percentage)46736.4
Moderate (60-79 percentage)34727
High (greater than or equal to 80 percentage)47036.6
Mean ± S.D. = 67.48 ± 13.44
Attitude toward MC
Poor (less than 60 percentage)36028
Fair (60-79 percentage)43934.2
Good (greater than or equal to 80 percentage)48537.8
Mean ± S.D. = 69.78 ± 15.47
Knowledge about MC
Low (less than 60 percentage)38630.1
Average (60-79 percentage)47136.7
Good (greater than or equal to 80 percentage)42733.3
Mean ± S.D. = 60.22 ± 21.00
Health Literacy for medicinal cannabis use dimensions
Inadequate (0-50 percentage)18914.7
Problematic (51-65 percentage)72656.5
Sufficient (66-84 percentage)19114.9
Excellent (85 percentage and over)17813.9
Mean ± S.D. = 63.50 ±12.84
Demand to MC use
No71956
Yes56544
Knowledge, Attitudes, Health Literacy, and Demand for MC A large majority of respondents (88.24%) reported having received information about MC (Table 1). The most common source of MC information was family (75.2%), television (52.6%), and social media (37.1%). Attitudes and knowledge about MC were well distributed with nearly equal numbers in the groups. Concerning health literacy, around half (56.5%) of the sample was categorized as having problematic health literacy. Overall, less than half of participants, (44.0%) report having a demand for MC (Table 1). Bivariable analysis of factors associated with demand for MC use Simple logistic regression was used to identify association between each individual independent variable and demand of MC use (Table 2). The independent factors that had p-value smaller than 0.25 were: age less than 30 (OR = 3.48; 95% CI: 1.72 – 7.03: p-value = 0.001), education higher than primary school (OR = 1.28; 95% CI: 1.01 – 1.61: p-value = 0.038), receiving health coverage outside the Universal Coverage Scheme (OR = 1.63; 95% CI: 1.27 - 2.10: p-value < 0.001), not have comorbidity (OR = 1.33; 95% CI: 1.05 – 1.68: p-value = 0.020), time from cancer diagnosis of 12 months or more (OR = 1.40; 95% CI: 1.04 – 1.88: p-value = 0.026), having previously received information about MC (OR = 1.58; 95% CI: 1.10 - 2.25: p-value = 0.012), high level of social support (OR = 6.66; 95% CI: 5.06 – 8.77; p-value <0.001), good attitude toward MC use (OR = 4.03; 95% CI: 3.04 – 5.34; p-value <0.001), good knowledge about MC use (OR = 2.76; 95% CI: 2.13 – 3.58; p-value <0.001), and adequate to excellent levels of health literacy about MC (OR = 10.92; 95% CI: 8.09 – 14.73; p-value <0.001).(Table 2.)
Table 2

The Bivariable Analysis of Factors Associated with Demand to MC Use among Cancer Patients in the Northern of Thailand. (n=1,284)

FactorsNumber% Demand to MC useCrude OR95% CIP-value
Sex0.184
Male49246.341-
Female79242.550.850.68 - 1.07
Age (years)0.001
≥301,24443.091-
< 304072.53.481.72 - 7.03
Current relationship status0.236
Single/divorced/separated/widowed33041.211-
Married/domestic partnership95444.971.160.90 - 1.50
Completed education0.038
Primary school83141.881-
Junior/senior high school/trade or vocational training/University degree45347.91.271.01 - 1.60
Scheme0
Universal coverage94840.821-
Civil servant medical benefit /social security scheme33652.981.631.27 - 2.09
Monthly income (THB)0.105
≤ 10,00086742.451-
≥10,00141747.241.210.96 - 1.53
Health status0.02
Comorbidity89141.861-
Not have comorbidity39348.851.321.04 - 1.68
Time from diagnosis with cancer (month)0.026
< 12 1,07242.631-
≥1221250.941.391.04 - 1.87
Received information about cannabis0.012
No15134.441-
Yes1,13345.281.571.10 - 2.24
Social support0
Low46717.771-
Moderate to high817596.655.05 - 8.76
Attitude toward MC0
Poor36021.671-
Fair to Good92452.714.023.03 - 5.34
Knowledge about MC use0
Low38627.461-
Average to good89851.112.762.13 - 3.57
Health literacy about MC
Inadequate- Problematic91528.851-0
Adequate- Excellent36981.5710.918.09 - 14.72
Multivariable analysis of factors associated with demand for MC use The multivariable analysis using GLMM with backward elimination indicated that the factors significantly associated with demand to MC use were: young age of <30 years old (adj.OR =1.89; 95% CI: 1.21 to 2.93), long time from diagnosis with cancer (adj.OR =1.73; 95% CI: 1.19 to 2.52), high social support (adj.OR =5.50; 95% CI: 3.60 to 8.39), positive attitude toward MC use (adj.OR = 2.56; 95% CI: 1.83 to 3.56), and Adequate- excellenthealth literacy about MC (adj.OR = 5.70; 95% CI: 4.08 to 7.96) when controlling other covariates (Table 3).
Table 3

The Multivariable Analysis of Factors Associated with Demand to MC Use among cancer patients in the Northern of Thailand. (n=1,284)

FactorsNumber% Demand to MC useCrude ORAdjust OR95% CIP-value
Age (years)0.005
≥301,24443.0911-
< 304072.53.481.891.21 - 2.93
Time from diagnosis with cancer (month)0.004
< 121,07242.6311-
≥1221250.941.391.731.19 – 2.52
Social support< 0.001
Low46717.7711-
Moderate to high817596.655.53.60 – 8.39
Attitude toward MC use< 0.001
Poor36021.6711-
Fair to Good92452.714.022.561.83 - 3.56
Health literacy about MC< 0.001
Inadequate/ Problematic91528.8511-
Adequate/ Excellent36981.5710.915.74.08 - 7.96
Socio-Demographic Factors among Cancer Patients in the Northern of Thailand. (n=1,284) The Bivariable Analysis of Factors Associated with Demand to MC Use among Cancer Patients in the Northern of Thailand. (n=1,284) The Multivariable Analysis of Factors Associated with Demand to MC Use among cancer patients in the Northern of Thailand. (n=1,284)

Discussion

We found that 44.0% of cancer patients in the North of Thailand reported having demand for MC use. This finding was comparable to actual marijuana usage among cancer patients reported in Alberta, Canada (Martell et al., 2018) and in the US(Tringale et al., 2017).Those countries have a longer history of MC legalization compared to Thailand. The Thai government has only recently legalized MC use in 2019. Demand for MC use in Thai society may be enhanced by recent attention. After controlling the covariates with backward elimination in the multivariate analysis, five variables were significantly associated with demand for MC use among cancer patients in northern Thailand. Those variables were higher health literacy about MC,higher social support, positive attitude toward MC use, young age, and longer time from diagnosis with cancers. In our study, we also found that cancer patients that had adequate to excellent levels of health literacy about MC were 5.70 times more likely to report having demand to use MC when compared with those with insufficient and problematic levels of health literacy about MC. Health literacy has previously been shown to positively correlate with CAM usage (Smith et al., 2019). Another study reported that CAM usage was significantly associated with adequate levels of health literacy among whites in the U.S. (Bains et al., 2011). People who reported moderate to high levels of social support were 5.50 times more likely to report demand for MC use when compared with those with low levels of social support. Social support has been shown to be related to CAM use in cancer patients (Reblin et al., 2019). It may be that most of the participants received social support from close friends and family members who provided information about MC products for patients to use. Those participants who reported a fair to good attitude toward MC use were 2.56 times more likely to report demand for MC use when compared to those with poor attitudes toward MC use. A previous study measuring intention to use MC in northeast Thailand reported that those with positive attitudes toward MC were 3.74 times more likely to report having an intention to use MC when compared with those with poor to fair levels (Rakpanich et al., 2020). Cancer patients aged less than 30 years were 1.89 times more likely to reportdemand for MC use when compared with those aged 30 years or older in our study. Youth has commonly been reported as a factor positively associated with CAM usage, including herbs and supplements(Bonacchi et al.,2014).Similarly, younger cancer patients may be more likely to prefer biological alternative medicines, such as plant-based medicines(Ciarlo et al.,2021).Reasons for these differences in the younger age may be better health, faster recovery after cancer, higher tolerance of side effects from treatment, and better abilities in searching for information. Those participants who had been diagnosed at least 12 months earlier were 1.73 times more likely to report demand for MC use when compared with those diagnosed less than to 12 months. Previous studies have reported that time from diagnosis with cancer was positively correlated with CAM use in cancer patients (Truant et al., 2013). One possibleexplanation is that when a person transitions to chronic illness, they begin searching for information on how to take care of their own health, in turn increasing their health literacy, resulting in a decision to use MC. This cross-sectional study found that 44.0% of cancer patients in the North of Thailandreported demand to use MC. The significant factors associated with reported demand to use MC were adequate to excellent levels of health literacy on MC use,moderate to high level of social support, fair to good attitudes about MC use, younger age, and longer time from diagnosis with cancer controlling for other covariates.

Author Contribution Statement

All authors contributed equally to this work.

Approval

The current study deals with primary data, so it doesn’t need from approval of scientific body. This paper is a part of the dissertation submitted in fulfillment of the requirements for the degree of Doctor of Public Health Program, Faculty of Public Health, Khon Kaen University, Thailand.

Funding Statement

The research is not funded by a specific project grant, but rather from personal fund of the authors.

Availability of data

The datasets are not publicly available due to ethical restrictions but are available from the corresponding author on reasonable request.

Conflict of interest

All authors declared no conflict of interest.
  26 in total

1.  Perceived support for medical cannabis use among approved medical cannabis users in Canada.

Authors:  Cesar Leos-Toro; Samantha Shiplo; David Hammond
Journal:  Drug Alcohol Rev       Date:  2018-06-05

2.  Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Authors:  Merry Jennifer Markham; Kerri Wachter; Neeraj Agarwal; Monica M Bertagnolli; Susan Marina Chang; William Dale; Catherine S M Diefenbach; Carlos Rodriguez-Galindo; Daniel J George; Timothy D Gilligan; R Donald Harvey; Melissa L Johnson; Randall J Kimple; Miriam A Knoll; Noelle LoConte; Robert G Maki; Jane Lowe Meisel; Jeffrey A Meyerhardt; Nathan A Pennell; Gabrielle B Rocque; Michael S Sabel; Richard L Schilsky; Bryan James Schneider; William D Tap; Robert G Uzzo; Shannon Neville Westin
Journal:  J Clin Oncol       Date:  2020-02-04       Impact factor: 44.544

3.  Patterns of complementary and alternative medicine use and health literacy in general practice patients in urban and regional Australia.

Authors:  Dora M von Conrady; Andrew Bonney
Journal:  Aust Fam Physician       Date:  2017

4.  Medical Cannabis Use in Glioma Patients Treated at a Comprehensive Cancer Center in Florida.

Authors:  Maija Reblin; Solmaz Sahebjam; Noah C Peeri; Yessica C Martinez; Zachary Thompson; Kathleen M Egan
Journal:  J Palliat Med       Date:  2019-05-13       Impact factor: 2.947

5.  Complementary and alternative medicine use among elderly patients living with chronic diseases in a teaching hospital in Ethiopia.

Authors:  Asnakew Achaw Ayele; Henok Getachew Tegegn; Kaleab Taye Haile; Sewunet Admasu Belachew; Amanual Getnet Mersha; Daniel Asfaw Erku
Journal:  Complement Ther Med       Date:  2017-10-27       Impact factor: 2.446

6.  Rates of cannabis use in patients with cancer.

Authors:  K Martell; A Fairchild; B LeGerrier; R Sinha; S Baker; H Liu; A Ghose; I A Olivotto; M Kerba
Journal:  Curr Oncol       Date:  2018-06-28       Impact factor: 3.677

7.  Complementary and alternative medicine use and its association with quality of life among Lebanese breast cancer patients: a cross-sectional study.

Authors:  Farah Naja; Romy Abi Fadel; Mohamad Alameddine; Yasmin Aridi; Aya Zarif; Dania Hariri; Anas Mugharbel; Maya Khalil; Zeina Nahleh; Arafat Tfayli
Journal:  BMC Complement Altern Med       Date:  2015-12-22       Impact factor: 3.659

8.  National and Subnational Population-Based Incidence of Cancer in Thailand: Assessing Cancers with the Highest Burdens.

Authors:  Shama Virani; Surichai Bilheem; Wasan Chansaard; Imjai Chitapanarux; Karnchana Daoprasert; Somsak Khuanchana; Atit Leklob; Donsuk Pongnikorn; Laura S Rozek; Surattaya Siriarechakul; Krittika Suwanrungruang; Sukit Tassanasunthornwong; Patravoot Vatanasapt; Hutcha Sriplung
Journal:  Cancers (Basel)       Date:  2017-08-17       Impact factor: 6.639

9.  Purposeful selection of variables in logistic regression.

Authors:  Zoran Bursac; C Heath Gauss; David Keith Williams; David W Hosmer
Journal:  Source Code Biol Med       Date:  2008-12-16

10.  A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy.

Authors:  Michelle Sexton; Carrie Cuttler; John S Finnell; Laurie K Mischley
Journal:  Cannabis Cannabinoid Res       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.